Development and Validation of a Bioanalytical HPLC Method for Quantification of Valsartan in Human Plasma and its Application in Pharmacokinetics Studies-Reference-Cited by-同舟云学术

Development and Validation of a Bioanalytical HPLC Method for Quantification of Valsartan in Human Plasma and its Application in Pharmacokinetics Studies

Published:2019-09-03 Issue:5 Volume:9 Page:672-681
ISSN:2229-7928
Container-title:Analytical Chemistry Letters
language:en
Short-container-title:Analytical Chemistry Letters

Author:

Tammam Marwa H.¹,Abo-Talib Nisreen F.¹

Affiliation:

1. Bioavailability center, National Organization for Drug Control and Research (NODCAR), P.O. Box 29 Giza, Egypt

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/22297928.2019.1684362

Reference25 articles.

1. ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary

2. High-performance liquid chromatographic analysis of angiotensin II receptor antagonist valsartan using a liquid extraction method

3. Pharmacokinetics, disposition and biotransformation of [14C]-radiolabelled valsartan in healthy male volunteers after a single oral dose

4. Simultaneous determination of hydrochlorothiazide and several angiotensin-II-receptor antagonists by capillary electrophoresis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determination of valsartan and pitavastatin using synchronous spectrofluorimetry and augmented least squares chemometric models: A comparative study with greenness and blueness assessment;Luminescence;2024-06

2. A mini Review on Analytical and Bioanlytical Techniques in Study of Drugs-Protein Interaction;Asian Journal of Research in Chemistry;2024-04-30

3. Spectrophotometric, chromatographic and bioanalysis of selected recently approved drugs from 2015–2020 to treat cardiovascular diseases: an analytical review;Bulletin of the National Research Centre;2023-02-20